People aged 75 to 79, as well as people who turned 80 after 1 September 2024, are eligible for a vaccine to protect against respiratory syncytial virus (RSV). RSV affects the airways and lungs and can ...

KureCare is expanding its Medicare-covered wound treatment access ahead of January 2026 CMS reimbursement changes. New ...

A technology developed in the laboratory of Prof. Amit Meller from the Technion—Israel Institute of Technology Faculty of ...

Columnist Mary Shaniqua lives with constant pain from sickle cell disease. Lately, it's taken the form of an excruciating ...

Diphtheria remains a threat, but effective management hinges on rapid access to both antibiotics and a critically scarce diphtheria antitoxin (DAT).

All La Roche-Posay products are 20 percent off at Dermstore’s sale, including the best affordable moisturizer for sensitive ...